[HTML][HTML] Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis
M Lorena, M Bellan, M Lepore, D Sola… - Journal of Clinical …, 2022 - mdpi.com
Liver involvement in systemic sclerosis (SSc) is rare. We evaluated the prevalence of liver
fibrosis and hepatic autoimmunity in SSc patients in a retrospective observational cohort (97 …
fibrosis and hepatic autoimmunity in SSc patients in a retrospective observational cohort (97 …
[HTML][HTML] Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis
G Cuomo, C Iandoli, R Galiero, A Caturano, C Di Vico… - Diagnostics, 2023 - mdpi.com
Background Systemic sclerosis (SSc) is a rare, multisystemic disorder of connective tissue
characterized by widespread inflammation, vascular abnormalities, and both skin and …
characterized by widespread inflammation, vascular abnormalities, and both skin and …
[PDF][PDF] Disease duration and Medsger's severity score are associated with significant liver fibrosis in patients with systemic sclerosis
SW Lee, BK Kim, JY Park, DY Kim, SH Ahn… - Clin Exp …, 2015 - clinexprheumatol.org
Objective. We investigated the prevalence and predictors of significant liver fibrosis in
patients with systemic sclerosis (SSc) who had no evidences of liver diseases due to viral …
patients with systemic sclerosis (SSc) who had no evidences of liver diseases due to viral …
[HTML][HTML] Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?
G Tarantino, A Spanò, G Loi, A Parisi… - World Journal of …, 2011 - ncbi.nlm.nih.gov
AIM: To investigate the spleen vascular involvement and the presence of liver fibrosis in a
population of subjects with established systemic sclerosis (SSc). METHODS: In a cross …
population of subjects with established systemic sclerosis (SSc). METHODS: In a cross …
Incidence and Predictors of an Abnormal Liver Function Test Among 674 Systemic Sclerosis Patients: A Cohort Study
K Sawadpanich, P Promasen, P Mairiang… - Open Access …, 2023 - Taylor & Francis
Background Abnormal liver function tests (LFTs) can indicate cirrhosis or liver cancer
leading to mortality among systemic sclerosis (SSc) patients. No recent studies have …
leading to mortality among systemic sclerosis (SSc) patients. No recent studies have …
Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome
SW Lee, BK Kim, JY Park, DY Kim, SH Ahn… - Modern …, 2016 - academic.oup.com
Objectives: To investigate the prevalence and the predictors of silent but substantial liver
fibrosis in patients with primary Sjogren's syndrome (pSS). Methods: We enrolled 101 pSS …
fibrosis in patients with primary Sjogren's syndrome (pSS). Methods: We enrolled 101 pSS …
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
Objective In retrospective studies, liver stiffness (LS) by vibration-controlled transient
elastography (VCTE) is associated with the risk of liver decompensation in patients with non …
elastography (VCTE) is associated with the risk of liver decompensation in patients with non …
[HTML][HTML] Liver fibrosis in primary Sjögren's syndrome
T Androutsakos, TA Voulgaris, AD Bakasis… - Frontiers in …, 2022 - frontiersin.org
Background Primary Sjögren syndrome (pSS) is a systemic autoimmune epithelitis,
potentially affecting salivary epithelium, biliary epithelium, and hepatocytes. Common …
potentially affecting salivary epithelium, biliary epithelium, and hepatocytes. Common …
The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis
Objectives The absence of a serological surrogate outcome measure of fibrosis in systemic
sclerosis (SSc) is a major deficiency for intervention studies and clinical management. An …
sclerosis (SSc) is a major deficiency for intervention studies and clinical management. An …
The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease
Background The prognosis of metabolic dysfunction‐associated steatotic liver disease
(MASLD) is associated with liver fibrosis. We investigated the associations between …
(MASLD) is associated with liver fibrosis. We investigated the associations between …